Our website uses its own and third parties cookies for a high level of user-friendliness. If you continue to browse and  use this website we will assume that you agree with the policies.

COVID-19

COVID-19

  • Covid-19 Tests
  • Companies
  • Individuals
  • Online consultations Covid-19

Atrys HealthAtrys

  • Español
  • English

Main navigation

  • Company
    • Presentation
    • Mission, vision and values
  • Laboratory
    • Laboratory
    • Test directory
    • Clinical trials and R&D services
    • Quality
    • Team
  • Telemedecine
    • What is telemedicine?
    • Radiology
    • Cardiology Cardiology
    • Ophthalmology
    • Dermatology
  • Radiotherapy
  • R&D
    • R&D
    • LIQUID BIOPSY
    • PROGNOSTIC ALGORITHMS
    • DATA INTEGRATION PLATFORMS
    • ONLINE DIAGNOSIS
    • OTHER PROJECTS
    • R&D services and training agreements
    • Publications and patents
  • Investors
  • News
  • Contact
    • Work with us
  • Private area

  • Español
  • English
  • Company
    • Presentation
    • Mission, vision and values
  • Laboratory
    • Laboratory
    • Test directory
      • Anatomic Pathology
      • Cytology
      • Hematology
      • Diagnostic Second Opinion
    • Clinical trials and R&D services
    • Quality
    • Team
  • Telemedecine
    • What is telemedicine?
    • Radiology
    • Cardiology Cardiology
    • Ophthalmology
    • Dermatology
  • Radiotherapy
  • R&D
    • R&D
    • LIQUID BIOPSY
      • BLI-O
      • S100P
      • Surveprost
      • Aptalung
      • InmunoSIGHT
      • Oncoporecise
      • Glibioliquid
      • Metabreast
      • PREDIAPT
      • ONCLIC
    • PROGNOSTIC ALGORITHMS
      • RADIOPROLIQ
      • 3TR
      • Predictgyn
      • Tradion P
      • Anxarecu
      • Precisesads
      • Oncoexpert
      • Prostatepredict
      • IHC and FISH study of EGFRvIII and PTEN expression in relapsed high grade gliomas
      • Identification of a predictive model for therapeutic guidance in cerebral tumors (gliomas) by means of systems pathology
      • Identificación de un modelo predictivo de opción terapéutica en cáncer de mama mediante la aplicación de la Patología Molecular y de Sistemas
      • Identificación de un modelo predictivo de opción terapéutica en linfomas de célula grande (DLBCL) mediante la aplicación de Patología de Sistemas
    • DATA INTEGRATION PLATFORMS
      • Plataforma de ayuda a la detección temprana de enfermedades infecciosas, mediante la identificación local de patógenos a partir de resultados de analíticas provenientes de laboratorios de análisis mediante técnicas de big data y hacking ético
    • ONLINE DIAGNOSIS
      • Daplia
      • eDCardio
      • eDSalud
      • eHealth areas in Hotels
    • OTHER PROJECTS
      • TheraYAP
      • Gliomatherapy
      • Papiloma
      • Zitomab
      • System of pharmacogenomic evaluation for breast cancer treatment with aromatase inhibitors according to a new application designed by ROVI Laboratories
      • CoVIg3
      • RAP-ID19
    • R&D services and training agreements
    • Publications and patents
      • Methods for prognosis of diffuse large b-cell lymphoma
      • EGFR and PTEN gene alterations predicts survival in patients with brain tumors
      • Monoclonal antibodies for the diagnosis, treatment and/or prevention of brain tumors and brain lesions
  • Investors
  • News
  • Contact
    • Work with us

Private area

MAB - Mercado Alternativo Bursátil

Research and development

  • R&D
  • LIQUID BIOPSY
  • PROGNOSTIC ALGORITHMS
  • DATA INTEGRATION PLATFORMS
  • ONLINE DIAGNOSIS
  • OTHER PROJECTS
  • R&D services and training agreements
  • Publications and patents
  • R&D
  • LIQUID BIOPSY
  • PROGNOSTIC ALGORITHMS
  • DATA INTEGRATION PLATFORMS
  • ONLINE DIAGNOSIS
  • OTHER PROJECTS
  • R&D services and training agreements
  • Publications and patents

Publications and patents

  • Articles and patents

Atrys has an intense R&D commitment, and allocates a significant portion of its human and material resources to the development of new approaches for personalized diagnosis and translational research.

Some of the R&D activities have generated international patent applications, as well as publications of scientific papers in international journals.

Publications

J Transl Med. (2019)

Polyethilene glycol improves current methods for circulating extracellular vesicle-derived DNA isolation

García-Romero N, Madurga R, Rackov G, Palacín-Aliana I, Núñez-Torres R, Asensi-Puig A, Carrión-Navarro J, Esteban-Rubio S, Peinado H, González-Neira A, González-Rumayor V, Belda-Iniesta C, Ayuso-Sacido A 

BMC Res Notes (2019)

Multiple immunofluorescence assay identifies upregulation of Active β-catenin in prostate cancer

Pere Puig, Nadina Erill, Marta Terricabras, Isaac Subirana, Judit González‑García, Adrià Asensi‑Puig, Michael J. Donovan, Lourdes Mengual, M.Teresa Agulló‑Ortuño, Mireia Olivan, Antonio Alcaraz, José A. López‑Martín, Inés de Torres, José Luis Rodríguez‑Peralto, Alfredo Rodríguez‑Antolín, Juan Morote and Víctor González‑Rumayor

Bioinformatics (2018)

ImaGEO: integrative gene expression meta-analysis from GEO database

Daniel Toro-Domínguez, Jordi Martorell-Marugán, Raúl López-Domínguez, Adrián García-Moreno, Víctor González-Rumayor, Marta E Alarcón-Riquelme, Pedro Carmona-Sáez

Oncotarget. 2015 Apr 30;6(12):10604-16.

Molecular profiling of peripheral blood is associated with circulating tumor cells content and poor survival in metastatic castration-resistant prostate cancer.

Marín-Aguilera M, Reig Ò, Lozano JJ, Jiménez N, García-Recio S, Erill N, Gaba L, Tagliapietra A, Ortega V, Carrera G, Colomer A, Gascón P, Mellado B.

Arthritis Rheumatol. 2016 Sep 6. doi: 10.1002/art.39857.

Granzyme A contributes to inflammatory arthritis through stimulation of osteoclastogenesis

Santiago L, Menaa C, Arias M, Martin P, Jaime-Sánchez P, Metkar S, Comas L, Erill N, Gonzalez-Rumayor V, Esser E, Galvez EM, Raja S, Simon MM, Sprague SM, Gabay C, Martinez-Lostao L, Pardo J, Froelich CJ

Mol Cancer Ther. 2014 May;13(5):1270-84. doi: 10.1158/1535-7163.MCT-13-0775. Epub 2014 Mar 21.

Epithelial-to-mesenchymal transition mediates docetaxel resistance and high risk of relapse in prostate cancer.

Marín-Aguilera M, Codony-Servat J, Reig Ò, Lozano JJ, Fernández PL, Pereira MV, Jiménez N, Donovan M, Puig P, Mengual L, Bermudo R, Font A, Gallardo E, Ribal MJ, Alcaraz A, Gascón P, Mellado B.

J Neurooncol. 2014 Jan;116(2):413-9. doi: 10.1007/s11060-013-1316-y. Epub 2013 Dec 19.

Efficacy of erlotinib in patients with relapsed gliobastoma multiforme who expressed EGFRVIII and PTEN determined by immunohistochemistry.

Gallego O, Cuatrecasas M, Benavides M, Segura PP, Berrocal A, Erill N, Colomer A, Quintana MJ, Balaña C, Gil M, Gallardo A, Murata P, Barnadas A.

Haematologica. 2013 Oct;98(10): 1554-1562. doi:10.3324/haematol.2013.086173. Epub 2013 May 28

MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy.

Valera A, López-Guillermo A, Cardesa-Salzmann T, Climent F, González-Barca E, Mercadal S, Espinosa I, Novelli S, Briones J, Mate JL, Salamero O, Sancho JM, Arenillas L, Serrano S, Erill N, Martínez D, Castillo P, Rovira J, Martínez A, Campo E, Colomo L; Grup per l’Estudi dels Limfomes de Catalunya i Balears (GELCAB)

Inflamm Bowel Dis. 2011 Jul;17(7):1490-500. doi: 10.1002/ibd.21507. Epub 2010 Nov 8.

Apoptosis resistance of mucosal lymphocytes and IL-10 deficiency in patients with steroid-refractory Crohn's disease.

Santaolalla R, Mañé J, Pedrosa E, Lorén V, Fernández-Bañares F, Mallolas J, Carrasco A, Salas A, Rosinach M, Forné M, Espinós JC, Loras C, Donovan M, Puig P, Mañosa M, Gassull MA, Viver JM, Esteve M.

Patents

P7304PC00-PCT/EP2012/067815:

Methods for prognosis of diffuse large b-cell lymphoma

PCT/EP2010/069058:

EGFR and PTEN gene alterations predicts survival in patients with brain tumors

EP14382545.3:

Monoclonal antibodies for the diagnosis, treatment and/or prevention of brain tumors and brain lesions
  • R&D
  • LIQUID BIOPSY
  • PROGNOSTIC ALGORITHMS
  • DATA INTEGRATION PLATFORMS
  • ONLINE DIAGNOSIS
  • OTHER PROJECTS
  • R&D services and training agreements
  • Publications and patents
  • R&D
  • LIQUID BIOPSY
  • PROGNOSTIC ALGORITHMS
  • DATA INTEGRATION PLATFORMS
  • ONLINE DIAGNOSIS
  • OTHER PROJECTS
  • R&D services and training agreements
  • Publications and patents
Atrys logo

Atrys Barcelona

C/Provença 392, planta baixa, 
08025, Barcelona

T: +34 934 815 561

info@atryshealth.com

Atrys Madrid

C/ Velázquez 24, 4ºIzq
28001 Madrid

T: +34 917 819 465

info@atryshealth.com

Atrys Granada

Edificio Genyo (PTCS)

Av. Ilustración 114 
18007  Granada

T: +34 958 715 500, ext. 125

info@atryshealth.com

Atrys Lugo

ICM/Atrys Division

Parque empresarial As Gándaras

Rúa María Barbeito, 61
27003 Lugo, España

T: +34 982 240 944
T: +34 902 212 054

Atrys Bogotá

Edificio Global Medical Center

Calle 116 No. 9 - 72, Oficina 410
Bogotá - Colombia

T: (571) 675 0195
T: 316 525 9414
T: 317 517 9533

teleradiologiadecolombia.com

Atrys Santiago de Chile

ITMS/Atrys Division

Av. Gertrudis Echeñique 30
Las Condes 71
Santiago de Chile

T: +56 (2) 2 437 49 04

www.itms.cl

Atrys Sao Paulo

AxisMed/Atrys Division

Avenida das Nações Unidas, 13.797
Bloco II - 18 andar
São Paulo – SP- Brasil

T: +55 11 3513 – 2924

www.portalaxismed.com.br

 

 

Web design | Legal advice